Tezepelumab COPD Exacerbation Study

NCT04039113 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

337

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

BIOLOGICAL: Tezepelumab
OTHER: Placebo

Sponsor

AstraZeneca

Collaborators

[object Object]